Month: July 2014
-
Andarix Pharmaceuticals Receives Pancreatic Cancer Orphan Drug Designation from the FDA
Tozaride is a potential breakthrough therapy for pancreatic cancer because patients will first be screened with its companion diagnostic, and only those patients who may be positive responders to the drug will be treated. Pancreatic cancer is responsible for significant cancer mortality in the United States, with over 50,000 new diagnoses and over 50,000 deaths…